Marlise R. Luskin, MD, MSCE

Trials

Studies that name Marlise R. Luskin, MD, MSCE as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:30 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT07227584 · ALL Backbone in AYAs

  Dana-Farber Cancer Institute · recruiting · Acute Lymphoblastic Leukemia, Philadelphia Chromosome-Negative Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia (ALL)
• Ph2
  NCT05303792 · Comparing Inotuzumab Combined With Low Intensity Chemotherapy Plus Blinatumomab to Usual Chemotherapy Plus Blinatumomab in Older Adults With CD22+ B-cell Acute Lymphoblastic Leukemia

  Alliance for Clinical Trials in Oncology · active not recruiting · B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma · study chair
• Ph1
  NCT05016947 · Venetoclax Plus Inotuzumab for B-ALL

  Dana-Farber Cancer Institute · active not recruiting · B-cell Acute Lymphoblastic Leukemia, B-Cell Lymphoma, ALL

Grants

NIH projects from RePORTER, fetched 2026-11-12 13:30 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Alliance for Clinical Trials in Oncology Member Site Core
  U10CA180821 · NCI · ALLIANCE NCTN FOUNDATION · PI Evanthia Galanis · fiscal years 2014 to 2026
  Named on NCT05303792